CD79A and gonorrhea: Our previous studies demonstrated that IL-12/ms treatment during gonococcal infection induced the production of vaginal and serum IgG antibodies, as well as vaginal IgA antibodies against the homologous infecting strain of N. gonorrhoeae (8).